Pharmaspectra’s Global Meetings Coverage
With medical literature, it’s not only important to access the information from the tens of thousands of global sources, but to understand the historical context as well.
PHARMASPECTRA ANNOUNCES INVESTMENT IN ITS FUTURE GROWTH PLAN
Pharmaspectra receives funding from private equity firm, Inflexion.
Identifying Predatory Journals
The rise of these predatory journals has largely been driven by the “publish or perish” dictum predominant in academia, where careers, promotions, and funding can depend on publishing research. To identify these problematic publications, look for these hallmarks
Rethinking Journal Submissions
Where to Publish Drug Trial Results? Traditional Journal Rankings Fail to Deliver their Promised Impact